{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T03:31:44Z","timestamp":1784604704420,"version":"3.55.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,4,14]],"date-time":"2015-04-14T00:00:00Z","timestamp":1428969600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12885-015-1244-7","type":"journal-article","created":{"date-parts":[[2015,4,13]],"date-time":"2015-04-13T03:08:45Z","timestamp":1428894525000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Multiparametric MRI as an outcome predictor for anal canal cancer managed with chemoradiotherapy"],"prefix":"10.1186","volume":"15","author":[{"given":"Michael","family":"Jones","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Hruby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Stanwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Gallagher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jameen","family":"Arm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jarad","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,4,14]]},"reference":[{"key":"1244_CR1","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1002\/cncr.20364","volume":"101","author":"LG Johnson","year":"2004","unstructured":"Johnson LG, Madeleine MM, Newcomer LM, Schwartz SM, Daling JR. Anal cancer incidence and survival: the surveillance, epidemiology, and end results experience, 1973-2000. Cancer. 2004;101:281\u20138.","journal-title":"Cancer"},{"key":"1244_CR2","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1002\/cncr.20365","volume":"101","author":"JR Daling","year":"2004","unstructured":"Daling JR, Madeleine MM, Johnson LG, Schwartz SM, Shera KA, Wurscher MA, et al. Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer. Cancer. 2004;101:270\u201380.","journal-title":"Cancer"},{"key":"1244_CR3","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1056\/NEJM199711063371904","volume":"337","author":"M Frisch","year":"1997","unstructured":"Frisch M, Glimelius B, Van den Brule AJ, Wohlfahrt J, Meijer CJ, Walboomers JM, et al. Sexually transmitted infection as a cause of anal cancer. N Engl J Med. 1997;337:1350\u20138.","journal-title":"N Engl J Med"},{"key":"1244_CR4","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1056\/NEJM200003163421107","volume":"342","author":"DP Ryan","year":"2000","unstructured":"Ryan DP, Compton CC, Mayer RJ. Carcinoma of the anal canal. N Engl J Med. 2000;342:792\u2013800.","journal-title":"N Engl J Med"},{"key":"1244_CR5","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1634\/theoncologist.12-5-524","volume":"12","author":"HE Uronis","year":"2007","unstructured":"Uronis HE, Bendell JC. Anal cancer: an overview. Oncologist. 2007;12:524\u201334.","journal-title":"Oncologist"},{"key":"1244_CR6","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1002\/ijc.24215","volume":"124","author":"BE Hoots","year":"2009","unstructured":"Hoots BE, Palefsky JM, Pimenta JM, Smith JS. Human papillomavirus type distribution in anal cancer and anal intraepithelial lesions. Int J Cancer. 2009;124:2375\u201383.","journal-title":"Int J Cancer"},{"key":"1244_CR7","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1007\/BF02586980","volume":"17","author":"ND Nigro","year":"1974","unstructured":"Nigro ND, Vaitkevicius VK, Considine B. Combined therapy for cancer of the anal canal: a preliminary report. Dis Colon Rectum. 1974;17:354\u20136.","journal-title":"Dis Colon Rectum"},{"key":"1244_CR8","doi-asserted-by":"publisher","first-page":"v87","DOI":"10.1093\/annonc\/mdq171","volume":"21","author":"R Glynne-Jones","year":"2010","unstructured":"Glynne-Jones R, Northover JMA, Cervantes A, on behalf of the ESMO Guidelines Working Group. Anal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010;21:v87\u201392.","journal-title":"Ann Oncol"},{"key":"1244_CR9","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/S0140-6736(96)03409-5","volume":"348","author":"UKCCCR Anal Cancer Trial Working Party","year":"1996","unstructured":"UKCCCR Anal Cancer Trial Working Party. Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research. Lancet. 1996;348:1049\u201354.","journal-title":"Lancet"},{"key":"1244_CR10","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1200\/JCO.2011.35.4837","volume":"30","author":"D Peiffert","year":"2012","unstructured":"Peiffert D, Tournier-Rangeard L, Gerard JP, Lemanski C, Francois E, Giovannini M, et al. Induction chemotherapy and dose intensification of the radiation boost in locally advanced anal canal carcinoma: final analysis of the randomized UNICANCER ACCORD 03 trial. J Clin Oncol. 2012;30:1941\u20138.","journal-title":"J Clin Oncol"},{"key":"1244_CR11","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1001\/jama.299.16.1914","volume":"299","author":"JA Ajani","year":"2008","unstructured":"Ajani JA, Winter KA, Gunderson LL, Pedersen J, Benson III AB, Thomas Jr CR, et al. Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal. JAMA. 2008;299:1914\u201321.","journal-title":"JAMA"},{"key":"1244_CR12","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1200\/JCO.1996.14.9.2527","volume":"14","author":"M Flam","year":"1996","unstructured":"Flam M, John M, Pajak TF, Petrelli N, Myerson R, Doggett S, et al. Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study. J Clin Oncol. 1996;14:2527\u201339.","journal-title":"J Clin Oncol"},{"key":"1244_CR13","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1200\/JCO.1997.15.5.2040","volume":"15","author":"H Bartelink","year":"1997","unstructured":"Bartelink H, Roelofsen F, Eschwege F, Rougier P, Bosset JF, Gonzalez DG, et al. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol. 1997;15:2040\u20139.","journal-title":"J Clin Oncol"},{"key":"1244_CR14","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.2214\/AJR.06.1403","volume":"188","author":"D Koh","year":"2007","unstructured":"Koh D, Collins DJ. Diffusion-weighted MRI in the body: applications and challenges in oncology. Am J Roentgenol. 2007;188:1622\u201335.","journal-title":"Am J Roentgenol"},{"key":"1244_CR15","doi-asserted-by":"publisher","first-page":"3293","DOI":"10.1200\/JCO.2006.06.8080","volume":"24","author":"N Hylton","year":"2006","unstructured":"Hylton N. Dynamic contrast-enhanced magnetic resonance imaging as an imaging biomarker. J Clin Oncol. 2006;24:3293\u20138.","journal-title":"J Clin Oncol"},{"key":"1244_CR16","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S1470-2045(06)71012-9","volume":"8","author":"MA Zahra","year":"2007","unstructured":"Zahra MA, Hollingsworth KG, Sala E, Lomas DJ, Tan LT. Dynamic contrast-enhanced MRI as a predictor of tumour response to radiotherapy. Lancet Oncol. 2007;8:63\u201374.","journal-title":"Lancet Oncol"},{"key":"1244_CR17","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1002\/1097-0142(19951115)76:10<1731::AID-CNCR2820761009>3.0.CO;2-H","volume":"76","author":"JA Martenson","year":"1995","unstructured":"Martenson JA, Lipsitz SR, Lefkopoulou M, Engstrom PF, Dayal YY, Cobau CD, et al. Results of combined modality therapy for patients with anal cancer (E7283): an Eastern Cooperative Oncology Group study. Cancer. 1995;76:1731\u20136.","journal-title":"Cancer"},{"key":"1244_CR18","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1023\/A:1008295119573","volume":"8","author":"D Peiffert","year":"1997","unstructured":"Peiffert D, Seitz JF, Rougier P, Francois E, Cvitkovic F, Mirabel X, et al. Preliminary results of a phase II study of high-dose radiation therapy and neoadjuvant plus concomitant 5-fluorouracil with CDDP chemotherapy for patients with anal canal cancer: a French cooperative study. Ann Oncol. 1997;8:575\u201381.","journal-title":"Ann Oncol"},{"key":"1244_CR19","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S0167-8140(97)00192-8","volume":"46","author":"JP Gerard","year":"1998","unstructured":"Gerard JP, Ayzac L, Hun D, Romestaing P, Coquard R, Ardiet JM, et al. Treatment of anal canal carcinoma with high dose radiation therapy and concomitant fluorouracil-cisplatinum. Long-term results in 95 patients. Radiother Oncol. 1998;46:249\u201356.","journal-title":"Radiother Oncol"},{"key":"1244_CR20","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1002\/1097-0142(19830515)51:10<1826::AID-CNCR2820511012>3.0.CO;2-L","volume":"51","author":"ND Nigro","year":"1983","unstructured":"Nigro ND, Seydel HG, Considine B, Vaitkevicius VK, Leichman L, Kinzie JJ. Combined preoperative radiation and chemotherapy for squamous cell carcinoma of the anal canal. Cancer. 1983;51:1826\u20139.","journal-title":"Cancer"},{"key":"1244_CR21","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1002\/(SICI)1096-9098(199902)70:2<71::AID-JSO2>3.0.CO;2-Y","volume":"70","author":"K Hu","year":"1999","unstructured":"Hu K, Minsky BD, Cohen AM, Kelsen DP, Guillem JG, Paty PP, et al. 30\u00a0Gy may be an adequate dose in patients with anal cancer treated with excisional biopsy followed by combined-modality therapy. J Surg Oncol. 1999;70:71\u20137.","journal-title":"J Surg Oncol"},{"key":"1244_CR22","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.ijrobp.2007.06.072","volume":"70","author":"P Hatfield","year":"2008","unstructured":"Hatfield P, Cooper R, Sebag-Montefiore D. Involved-field, low-dose chemoradiotherapy for early-stage anal carcinoma. Int J Radiat Oncol Biol Phys. 2008;70:419\u201324.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1244_CR23","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1158\/1078-0432.CCR-08-1287","volume":"15","author":"S Kim","year":"2009","unstructured":"Kim S, Loevner L, Quon H, Sherman E, Weinstein G, Kilger A, et al. Diffusion-weighted magnetic resonance imaging for predicting and detecting early response to Chemoradiation therapy of squamous cell carcinomas of the head and neck. Clin Cancer Res. 2009;15:986\u201394.","journal-title":"Clin Cancer Res"},{"key":"1244_CR24","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1007\/s00330-012-2496-0","volume":"22","author":"G Somoye","year":"2012","unstructured":"Somoye G, Harry V, Semple S, Plataniotis G, Scott N, Gilbert FJ, et al. Early diffusion weighted magnetic resonance imaging can predict survival in women with locally advanced cancer of the cervix treated with combined chemo-radiation. Eur Radiol. 2012;22:2319\u201327.","journal-title":"Eur Radiol"},{"key":"1244_CR25","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1016\/j.ijrobp.2011.12.058","volume":"83","author":"M Ng","year":"2012","unstructured":"Ng M, Leong T, Chander S, Chu J, Kneebone A, Carroll S, et al. Australasian Gastrointestinal Trials Group (AGITG) contouring atlas and planning guidelines for intensity-modulated radiotherapy in anal cancer. Int J Radiat Oncol Biol Phys. 2012;83:1455\u201362.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1244_CR26","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.radonc.2013.08.002","volume":"109","author":"DC Gilbert","year":"2013","unstructured":"Gilbert DC, Williams A, Allan K, Stokoe J, Jackson T, Linsdall S, et al. p16INK4A, p53, EGFR expression and KRAS mutation status in squamous cell cancers of the anus: correlation with outcomes following chemo-radiotherapy. Radiother Oncol. 2013;109:146\u201351.","journal-title":"Radiother Oncol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-015-1244-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-015-1244-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-015-1244-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-015-1244-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T07:37:46Z","timestamp":1551166666000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-015-1244-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,14]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["1244"],"URL":"https:\/\/doi.org\/10.1186\/s12885-015-1244-7","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,14]]},"article-number":"281"}}